-transparent.png){kind=logo}
1. The pharmacokinetics and disposition of picumeterol, a novel beta 2 receptor agonist agent, have been studied in the rat and dog following administration by inhalation, intravenous and oral routes at various dose levels. 2. Picumeterol was found to be transferred across the lung of the rat and dog following inhalation dosage. After i.v. dosage picumeterol was eliminated from plasma with a half-life of about 1 h in the rat and about 2 h in the dog. Plasma clearance in the rat was about twice liver blood flow and the plasma levels of picumeterol were low after oral administration. 3. Following instillation of 14C-picumeterol to the trachea of isolated respiring rat lung preparations radioactivity was transferred from the airways to perfusion media as unchanged drug within 2 min. After 2 h perfusion, no metabolites were detected in the recirculation perfusate or lung. 4. Picumeterol was extensively metabolized in vivo in the rat (about 95%) and dog (about 90%) and in vitro in microsomal preparations of rat, dog and human liver. O-dealkylation and beta-oxidation are important as routes of metabolism. 5. Radioactivity was largely excreted in the urine of the rat and dog (> 50% of dose), as metabolites, following i.v. administration. There was some excretion of radioactivity in dog bile. Extensive first-pass metabolism was found after oral administration in the rat.
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
October 2019,
Environmental pollution (Barking, Essex : 1987),
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
October 1983,
British journal of clinical pharmacology,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
March 1999,
Xenobiotica; the fate of foreign compounds in biological systems,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
May 1978,
Xenobiotica; the fate of foreign compounds in biological systems,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
January 1976,
Clinical pharmacology and therapeutics,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
May 1984,
Journal of the American Veterinary Medical Association,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
October 1999,
Xenobiotica; the fate of foreign compounds in biological systems,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
January 1989,
Drug metabolism and disposition: the biological fate of chemicals,
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
August 1957,
Antibiotics & chemotherapy (Northfield, Ill.),
A Barrow, and
S J Camp, and
S Dayal, and
W N Jenner, and
D Lashmar, and
J M Oxford, and
E Palmer, and
N L Scully, and
G C Curtis, and
H M Hughes
October 1983,
Clinical pharmacology and therapeutics,
